Clinical Trial Update: Molecular Mechanisms of Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

The document reports the completion of a Phase 4 clinical trial focused on the molecular mechanisms of Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED